Data represents volume of test kits shipped for BARDA-supported SARS CoV-2 diagnostic tests. The FDA has granted EUA to over 300 diagnostic and serological tests. The USG is investing in diagnostics across the government. The cumulative shipment data above are from BARDA industry partners only, and do not reflect non-BARDA supported assays, all private efforts, or laboratory-developed diagnostics. The focus of the graph is to demonstrate BARDA’s commitment and rapid scale up of diagnostics as a component of this national response.